Publications by authors named "J HIRANO"

Electroconvulsive therapy (ECT) is one of the most effective treatments for depression. ECT induces volume changes in the amygdala, a key center of anxiety. However, the clinical relevance of ECT-induced changes in amygdala volume remains uncertain.

View Article and Find Full Text PDF

Background: Lung cancer is among the most common types of cancers worldwide, and surgery can be a curative treatment option for this condition. However, some patients experience postoperative recurrence. Hence, predicting early postoperative recurrence to improve patient prognosis is important.

View Article and Find Full Text PDF

In February 2004, the Food and Drug Administration (FDA) was the first to approve the combination of cisplatin (CDDP) and pemetrexed (PEM) as standard first-line chemotherapy for untreated, unresectable malignant pleural mesothelioma (MPM). However, after that approval, no progress was made in the standard first-line treatment of MPM for almost 15 years. Positive results from a phase 3 study (Mesothelioma Avastin Cisplatin Pemetrexed Study: MAPS) verifying the effect of bevacizumab, an anti-angiogenesis agent added to CDDP/PEM for unresectable MPM, were published in The Lancet in December 2015; however, this did not lead to approval by national drug regulatory agencies.

View Article and Find Full Text PDF

Figure-eight-shaped nonplanar π-systems adopt distinctive chiral -symmetric structures, which are ideal for realizing efficient circularly polarized luminescence (CPL). However, the short-step and enantioselective synthesis of figure-eight π-systems represents a considerable challenge for the conventional bottom-up synthetic strategy. Herein, we report that the oxidative cleavage of the internal double bond of a commercially available polycyclic aromatic hydrocarbon, i.

View Article and Find Full Text PDF
Article Synopsis
  • Neuroimaging databases for neuro-psychiatric disorders provide valuable data for researchers to explore diseases, develop machine learning models, and redefine understanding of these conditions.* ! -
  • A review identified 42 global MRI datasets totaling 23,293 samples from patients with various disorders, including mood, developmental, schizophrenia, Parkinson's, and dementia.* ! -
  • Improved governance and addressing technical issues of these databases are essential for sharing data across borders, aiding in understanding, diagnosing, and creating early interventions for neuro-psychiatric disorders.* !
View Article and Find Full Text PDF